Antibiotice
I · AI Analysis
The brief
Antibiotice manufactures generic medicines across multiple therapeutic categories — anti-infectives (including tuberculosis treatments), cardiovascular drugs, digestive tract and metabolism treatments, and gynecological preparations — available as injectables, tablets, capsules, creams, and suppositories [Yahoo Finance]. The company also produces active pharmaceutical ingredients, biofertilizers, disinfectants, and veterinary medicines, selling into approximately 70 countries from its base in Iași, Romania [Yahoo Finance].
Antibiotice is a Romanian state-controlled pharmaceutical manufacturer producing generic prescription drugs, active ingredients, and veterinary medicines for both the domestic market and exports to roughly 70 countries [Yahoo Finance]. The company is navigating a sharp profit decline while prioritizing a strategic investment program, and recently exceeded a debt threshold with its lenders [Ziarul Financiar]. Its trailing-twelve-month financials show falling revenue, compressed operating margins, and weak cash generation, placing it in a precarious financial position.
The company is under severe financial strain, with falling margins, negative free cash flow, and elevated debt.
Sentinellis health
Significant risks
2.9/10
7.5+ strong · 4.5–7.5 moderate · under 4.5 weak
Profitability
Returns on capital
Growth & momentum
Balance sheet
Cash generation
Value creation
Sentinellis calculation from the published statements — not a score reported by any data source. Each category is scored on the checks that had data; missing inputs are excluded rather than counted as failures.
Market capitalisation
RON 1.3B
Revenue (TTM)
RON 616.6M
II · Recent news
What moved
4 stories · ranked by relevance
- company2026-08-26
Bursă. Compania de stat Antibiotice Iaşi a depăşit un prag de îndatorare agreat cu băncile şi a mutat - Ziarul Financiar
Ziarul Financiar
- company2026-08-19
Antibiotice Iași distribuie doar un sfert din profitul net al anului trecut sub formă de dividend, propunere reluată după AGA din primăvară - profit.ro
profit.ro
- company2026-08-18
Antibiotice - profit în scădere abruptă; compania se concentrează pe programul investiţional strategic - Ziarul Bursa
Ziarul Bursa
- company2026-08-31
ZF 7.000. Ce mesaj transmite Ioan Nani, director general Antibiotice, după 7.000 de ediţii de ZF: „Ziarul - Ziarul Financiar
Ziarul Financiar
Premium · Free with any account
Operating margin fell 10.4 percentage points year-over-year (from 20.3% to 9.9%), meaning the company is earning far less from each unit of revenue even as total sales declined [Yahoo Finance]. This compression is a red flag independent of the investment cycle.
Risks
5
Opportunities
4
Red flags
4
Leadership
8
12 more findings in the full report — free with any account.
Unlock the full Antibiotice analysis
Create a free account to access the complete AI-generated report with inline citations.
- 5 risks, 4 opportunities and 4 red flags — each with its source
- 100+ financial metrics with charts and benchmarks
- Full news summaries with source links
- Executive team and compensation details
- PDF export for offline use
III · Related
You might also read
Same sector · Healthcare — or comparable health
Want this for your watchlist?